This might include: Slowly stopping the drug Eating well Staying active Getting support Summary Table For Side Effects Maximising Results with GLP-1s for Craving and Weight Control Healthy eating, physical activity, and behavioural support can improve overall treatment outcomes
Lifestyle modifications including diet, exercise and behavior change are also important components that must not be overlooked
Only choose such products under the supervision of a medical practitioner to avoid possible adverse reactions
The Importance of Addressing Excess Weight Living with excess weight can significantly increase your risk for a range of serious health issues, including type 2 diabetes, heart disease, high blood pressure, sleep apnea, joint pain, and certain cancers
Low Carb Diets & Protein Protein is everywhere in 2026
Foundayo (orforglipron) is Eli Lilly's small-molecule oral GLP-1 receptor agonist, FDA-approved on April 1, 2026 for chronic weight management in adults with obesity or overweight with a weight-related condition